CareDx(CDNA) - 2024 Q1 - Quarterly Results

Exhibit 99.1 BRISBANE, Calif., May 9, 2024, CareDx, Inc. (Nasdaq: CDNA) — today reported financial results for the first quarter ended March 31, 2024. • Reported first quarter revenue of $72.0 million. • SHORE data presented at ISHLT demonstrated that HeartCare® multimodal testing outperforms donor-derived cell-free DNA (dd-cfDNA) testing alone in identifying allograft rejection. "We set a new baseline in our Testing Services business in the second half of 2023 and are back to delivering sequential growth. ...